Close Menu

NEW YORK — Molecular diagnostics firm Lucira Health said on Tuesday that it has received $11.5 million to support its development of an over-the-counter influenza test under the second phase of a contract with the US Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA).

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.